News
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...
Over his eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company said. However, the shares ...
The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results